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Hybrid System for Ex 
Vivo Hemorheological and 
Hemodynamic Analysis: A 
Feasibility Study
Eunseop Yeom1, Yang Jun Kang2 & Sang Joon Lee1
Precise measurement of biophysical properties is important to understand the relation between 
these properties and the outbreak of cardiovascular diseases (CVDs). However, a systematic 
measurement for these biophysical parameters under in vivo conditions is nearly impossible 
because of complex vessel shape and limited practicality. In vitro measurements can provide more 
biophysical information, but in vitro exposure changes hemorheological properties. In this study, a 
hybrid system composed of an ultrasound system and microfluidic device is proposed for monitoring 
hemorheological and hemodynamic properties under more reasonable experimental conditions. 
Biophysical properties including RBC aggregation, viscosity, velocity, and pressure of blood flows are 
simultaneously measured under various conditions to demonstrate the feasibility and performance 
of this measurement system. The proposed technique is applied to a rat extracorporeal loop which 
connects the aorta and jugular vein directly. As a result, the proposed system is found to measure 
biophysical parameters reasonably without blood collection from the rat and provided more detailed 
information. This hybrid system, combining ultrasound imaging and microfluidic techniques to ex 
vivo animal models, would be useful for monitoring the variations of biophysical properties induced 
by chemical agents. It can be used to understand the relation between biophysical parameters and 
CVDs.
Cardiovascular diseases (CVDs) may result from rheological1–4 and hemodynamic5,6 abnormalities. 
Among them, blood viscosity is considered as a crucial factor in determining the physiological and 
pathological conditions of CVDs7, because it augments flow resistance and wall shear stress, which stim-
ulates the endothelial cells of blood vessels. The shear-thinning effect of blood under low shear condi-
tions is mainly attributed to the aggregation of red blood cells (RBCs). In this case, RBCs form rouleaux 
or 3D networks of RBC aggregates. Given that a considerable increase in RBC aggregation is somewhat 
correlated with CVDs8,9 RBC aggregation may also play an important role in understanding the etiolog-
ical cause of CVDs. For these reasons, the accurate measurement of hemorheological properties is essen-
tial to understand their role in the occurrence and development of CVDs and microcirculation diseases.
Several techniques have been introduced to effectively measure blood viscosity10–12. A H-shaped 
microfluidic device, composed of two parallel side channels and a bridge channel, can effectively measure 
blood viscosity under various flow conditions13. RBC aggregation can be measured directly (microscopic 
observation methods)14,15, or indirectly. The latter includes measurement modalities such as erythrocyte 
sedimentation rate16, light reflection or transmission17, ultrasonic18,19 and electrorheological methods20. 
However, most conventional methods measure hemorheological properties using collected blood.
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Hemorheological properties obtained under in vitro condition are different from the values measured 
directly from an animal model because of different experiment conditions21. In addition, the aggrega-
bility and deformability of RBCs are influenced by external exposure of blood samples22. Therefore, the 
results obtained by in vitro measurement need to be validated under in vivo conditions. However, it is 
technically difficult to accurately measure biophysical properties under in vivo conditions. To resolve 
these problems, a rat extracorporeal loop model, which circulates blood through an external network 
connecting large-scale artery and vein directly, was developed, recently23. By inserting an H-shaped 
microfluidic device into the rat extracorporeal loop, biophysical properties such as viscosity, flow rate, 
and pressure were measured as a function of elapsed time under ex vivo condition24–26. However, the flow 
rate of the blood delivered through the complex network was unspecified. To evaluate the unknown flow 
rate of blood, additional experimental procedure should be conducted using the blood sample collected 
from the rat extracorporeal model.
Recently, a high-frequency ultrasound system with speckle image velocimetry (SIV) was demonstrated 
to measure the velocity fields of blood flows with a reasonable accuracy. It applies a cross-correlation 
algorithm to ultrasound images of RBCs or RBC aggregates27,28. In addition, an ultrasound imaging 
system can capture spatial and temporal distributions of RBC aggregates19,29. Therefore, the information 
on the velocity fields of blood flows and the characteristics of RBC aggregation can be simultaneously 
obtained from the ultrasound imaging system.
A hybrid system composed of an ultrasound imaging system and a microfluidic device connected to 
a rat extracorporeal model is proposed to monitor temporal variations of hemorheological and hemo-
dynamic properties with better accuracy. This system has several distinctive advantages. First, the bio-
physical properties, including blood viscosity, mean pressure, blood flow, RBC aggregation, heart rate 
and temperature, of real blood circulating in the extracorporeal microfluidic loop can be simultane-
ously measured without noticeable hemorheological changes. Second, this system can be used to sen-
sitively monitor the temporal variations of hemorheological and hemodynamic parameters properties 
in a short-term period under ex vivo conditions such blood dialysis because the proposed system can 
measure these properties without blood collection from a rat model. The proposed system also might 
be utilized as a measurement tool for understand the relation between these properties and CVDs. In 
addition, the hemorheological properties at relatively low and high shear rate conditions can be simul-
taneously measured using microchannel and vascular phantom with different size. Lastly, the proposed 
method does not require any calibration procedures because it does not have any flow sensors.
To demonstrate the feasibility and usefulness of the proposed system combined with an ultrasound 
imaging modality and microfluidic device, the biophysical properties including RBC aggregation, blood 
flow velocity, and blood viscosity of blood samples are estimated under various in vitro conditions. 
Then, hybrid system is applied to the rat extracorporeal bypass model to monitor temporal variations of 
biophysical properties.
Results
Measurement of biophysical properties using the proposed system. Figure  1 shows a sche-
matic diagram of the proposed hybrid system to monitor temporal variations of biophysical properties 
under ex vivo conditions. The proposed system consists of a pulse-free apparatus (air cavity = 0.5 mL), 
a microfluidic device, an ultrasound imaging system, and a heat pad with monitoring system. The pul-
satile flow supplied from the aorta is stabilized by passing through the pulse-free chamber. Given that 
the blood circulating through the extracorporeal network is cooled, a heat pad is employed to maintain 
the body temperature of the rat model. To measure blood viscosity, a hydrodynamic balancing state is 
induced in the microfluidic device by adjusting the injection flow rate of a phosphate-buffered saline 
(PBS) solution with a syringe pump. Ultrasound images of blood flows in the extracorporeal loop are 
then acquired. The rectal temperature and heart rate are monitored simultaneously to check the biophys-
ical conditions of the rat model.
Hemorheological properties such as the degree and concentration of RBC aggregation, and disso-
ciation of RBC aggregates, and hemodynamic properties, including velocity profile and flow rate are 
measured by analyzing ultrasound images captured by an ultrasound imaging system. Blood viscosity 
and hydrodynamic balancing pressure in the microfluidic device are estimated by using the microfluidic 
device. As depicted in Fig.  1, a discrete fluidic circuit of the proposed system is composed of fluidic 
resistances, air compliance of the pulse-free apparatus, and flow rates. By adding pressure drops in the 
fluidic circuit model from hydrodynamic balancing pressure in the microfluidic device, the mean pres-


































where, Ln and Dn are the characteristic length and hydraulics diameter of a certain part in the extracor-
poreal network. PPBSB denotes the hydrodynamic balancing pressure of PBS solution. In this numerical 
prediction, it is assumed that blood viscosity is identical in every parts of a complex extracorporeal 
network and blood is circulated in the extracorporeal network without bleeding. 
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Estimation of RBC aggregation using ultrasound speckle images. To monitor temporal varia-
tions of RBC aggregation in a vascular phantom, ultrasound system is adopted (Fig. 2A). Given that the 
ultrasound signal amplitude of blood flows is determined by the size and amount of RBC aggregates, 
B-mode images show bright speckles at low flow rate conditions as shown in Fig. 2B. Speckle images are 
depicted in decibels (dB) by evaluating the ratio of the ultrasound signals of blood to PBS signals for 
clear comparison. Figure 2C shows radial variations of echogenicity obtained by averaging the B-mode 
images along the flow direction at different flow rates. As the blood flow rate decreases, a normal dis-
tribution of echogenicity with high values around the tube center is changed into a blunt shape with 
higher values. This phenomenon may be attributed to the fact that the decrease of shear force facilitates 
the formation of RBC aggregation and their propagation from the tube center to the near-wall region.
To quantify the degree of RBC aggregation, mean echogenicities (E) in the tube center (ranged from 
r/R = − 0.5 to 0. 5) of different flow rates are compared (Fig. 2D). A pseudo shear rate (γ pseudo) is adopted 
to represent shear force in the tube center by using the following equation:
Figure 1. A proposed hybrid system for ex vivo monitoring biophysical properties of blood. The system 
is composed of an ultrasound system and a microfluidic device for monitoring temporal variations of the 
biophysical properties of blood samples. The extracorporeal bypass loop consists of a pulse-free chamber (air 
cavity = 0.5 mL), a microfluidic device, and a vascular phantom for ultrasound imaging. Blood is supplied 
into the fluidic network by connecting the extracorporeal loop to blood vessels of a rat model. The body 
temperature of a rat model is maintained using a heat pad. To induce the hemodynamic balancing state in 
the microchannel, PBS solution is delivered as a reference fluid by a syringe pump. A discrete fluidic circuit 
of the proposed system is composed of fluidic resistances (R1…Rn, R1′, R2′, Rout), air compliance (C), flow 
rates (QBlood, QPBS). At the hemodynamic balancing state, the pressures (PBloodB, RPBSB) at both ends of the 
bridge channel are identical.
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where, D denotes the diameter of a vascular vessel and QBlood is the blood flow rate. As the pseudo shear 
rate decreases from 100 to 0.1 s−1, the echogenicity drastically increases due to the formation of RBC 
aggregates. Given that RBC aggregation is more enhanced at a relatively low shear rate of 0.1 s−1 com-
pared with no shear condition30, the maximum echogenicity of RBCs in autologous plasma is observed 
around the pseudo shear rate of 0.1 s−1. However, for low shear rates ranging from 0.01 to 0.5 s−1, the 
variation of echogenicity is not so significant.
To change hemorheological properties, RBCs suspended in PBS solution, and dextran and 4,4
′ -diisothiocyanatostilbene-2,2′ -disulfonic acid (DIDS) treated plasmas are compared with RBCs in 
autologous plasma. Considering that the dextran treatment ascertains intercellular interactions between 
Figure 2. Estimation of RBC aggregation by analyzing ultrasound images of blood flows. (A) A 
schematic of the ultrasound imaging system. Blood is delivered into the vascular phantom with an acoustic 
absorber to minimize ultrasound artifacts. (B) Typical speckle images of blood flows at different flow rates. 
Speckle images are obtained by averaging a total of 255 ultrasound images. For easy comparison, the 
corresponding images with false colors representing the logarithm of signal power in decibels are included. 
Decibel is calculated by dividing blood signals to water signals. (C) Radial variations of the mean 
echogenicity of blood flows shown in Fig. 2B. Error bars indicate the standard deviation (n = 255). (D) 
Variations of mean echogenicity (E) in the center of tube (ranged from − 0.25 to 0.25 of normalized radius) 
according to pseudo shear rate ( Pseudoγ ) among four different groups. Error bars indicate the standard 
deviation (n = 2). (a–d) Ultrasound B-mode images for four different groups at a flow rate of 5 mL/h. (E) 
Variations of kurtosis (K) in the center of tube according to pseudo shear rate. Error bars indicate the 
standard deviation (n = 2). Histograms of echo speckle amplitude data (G) of RBCs in autologous plasma at 
a flow rate of (a) 0.05, (b) 5, and (c) 300 mL/h.
www.nature.com/scientificreports/
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RBCs, the echogenicity of RBCs in the dextran-treated plasma has significantly large values. It is difficult 
to precisely distinguish the changes in echogenicity for the dextran case under low shear conditions. In 
contrast, the DIDS treatment effectively inhibits the formation of RBC aggregates, but the echogenicity 
is slightly increased under low shear rate conditions. Given that RBCs in PBS solution are completely 
dispersed, the echogenicity is almost similar regardless of shear rate.
Ultrasound blood speckles are composed of many independent scatters including RBCs and RBC 
aggregates. When backscattered signals have Gaussian distribution, Rayleigh scattering is dominant in 
the captured ultrasound images according to the central limit theorem29. To investigate the concentration 
of scatters, a statistical analysis is conducted for various speckle images (Fig. 2E). Considering that the 
kurtosis (K) of Gaussian distribution is zero, the kurtosis for RBCs in PBS solution with similar to zero 
value can be explained by assumption that completely dispersed RBCs can be considered as Rayleigh 
scatters. However, this consideration may not always be valid for echogenicity scattered by RBCs or RBC 
aggregates. As shown in Fig. 2E(a–c), speckle images of many large RBC aggregates exhibits a leptokurtic 
distribution with a high mean value. As a result, the RBCs in the autologous and dextran-treated plasma 
have kurtosis values of nearly zeros under very low shear rate conditions. Speckle images of blood with 
relatively small RBC aggregates have a platykurtic distribution, resulting in negative kurtosis. Specific 
shear rate condition with a minimum kurtosis is quite different among groups, because chemical treat-
ments with dextran and DIDS change RBC aggregability noticeably. As the shear rate increases beyond 
the specific shear rate, kurtosis values approach zero because of dispersion of RBC aggregates.
Velocity field and flow rate of a newtonian fluid. The performance of the ultrasound imaging 
system used in this study is validated by applying it to a Newtonian fluid (PBS solution). Given that 
ultrasound agents have been commonly used for quantitative visualization of opaque flows31–33, micro-
bubbles are used as tracer particles to measure velocity field of a PBS flow. As shown in Fig.  3A, the 
microbubbles used in this study have a hollow structure. Morphological characteristics of the microbub-
bles are quantified using digital image processing techniques. The mean diameter of the microbubbles is 
measured as 2.13 μ m (Fig. 3B).
PBS solution seeded with microbubbles is delivered by a syringe pump into the vascular phantom at 
a flow rate of 10 mL/h. Figure  3C shows typical velocity field obtained from ultrasound images of the 
PBS flow. The velocity profiles are symmetric with respect to the center of the vessel. To compare the 
measured velocity profiles with the analytical solution, radial velocity profiles are obtained by averaging 
the entire velocity fields along the flow direction (Fig. 3D). Velocity profile and radial position are nor-
malized by dividing with the maximal velocity and vessel radius, respectively. The flow rate (Q) evaluated 
by following equation based on a fitting model is compared to injection flow rate of the syringe pump;
Q R V B
B 2 3
2
maxπ= + ( )
where Vmax is the maximum velocity at the vessel center, and R represents the vessel radius. A blunt-
ness index (B) describes the flatness of the velocity profile. For instance, the normal velocity profile 
with a bluntness index of 2 is parabolic. When the bluntness index is larger than 2, the profile has a 
blunt shape28. The flow rate estimated by Eq. (3) is about 9.89 mL/h with a bluntness index of B = 2.01. 
Therefore, the measured velocity profile is in a good agreement with the analytical solution. This finding 
implies that the present ultrasound system can be reasonably used to measure velocity field information.
Blood flows and dissociation of RBC aggregates. Different from a Newtonian fluid, blood flows 
are varied according to physiological conditions26,34. Velocity fields of RBCs in autologous plasma at 
various flow rates are measured by using the SIV technique28,35. Figure 4A shows a typical instantaneous 
velocity field of a blood flow in the vascular phantom at a flow rate of 10 mL/h. Spatial distribution of 
corresponding shear rate is superimposed on the velocity field. Shear rate has a maximum value at the 
vascular wall and zero value in the tube center. Figure 4B shows the velocity profiles measured at six flow 
rates. As expected, the velocity profiles become blunt with decreasing flow rate26.
By applying Eq. (3), the flow rate of each blood flow is estimated. Figure  4C compares the esti-
mated flow rates of RBCs in autologous plasma and injection flow rates supplied by the syringe pump. 
Bland–Altman analysis is adopted for a more detailed comparison of the flow rates estimated by the 
SIV technique with injection flow rate36. In the Bland–Altman plot of Fig. 4C(a), the difference between 
two techniques is depicted against their average values. A bold line and dashed lines indicate the mean 
value and ± 95% limits of agreement, respectively. Given that the presentation of data inside the 95% 
limits is utilized to judge the agreement of two methods, the flow rates measured by the SIV technique 
are in a good agreement with the injection flow rates, except for the high flow rate region. As shown in 
Fig. 4C(b), percentage errors are also evaluated to compensate for the large variances in high flow rate 
condition. Unlike the Bland–Altman analysis, the percentage errors at low flow rates have relatively high 
values although they are less than 10%. This phenomenon results from unstable behaviors of the syringe 
pump at a low flow rate, and from the significantly small displacement of speckles in ultrasound images.
An additional biophysical parameter about RBC aggregation can also be measured using the present 
methods. As illustrated in Fig.  4D(a), the spatial distribution of RBC aggregates aligned with the flow 
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direction at a specific time (t) varies due to shear force during the time interval (Δ t). Considering 
that variations in spatial distribution of scatters lead to change of speckle images, the decorrelation of 
blood speckles (DS) based on speckle similarity can be used to estimate the degree of dissociation of 
RBC aggregates. Figure  4D shows variations of dissociation with respect to the pseudo shear rate for 
four different groups. As the pseudo shear rate increases beyond a specific value, the decorrelation val-
ues for all groups are dramatically raised. Weak intercellular interactions of RBCs in PBS solution and 
DIDS-treated plasma bring about high decorrelation values over all shear rate conditions. The break-
down of rouleaux into individual cells is restrained in dextran-treated plasma because of enhanced RBC 
aggregation. Therefore, the decorrelation of speckles for dextran-treated group has the lowest values for 
all shear rate conditions.
Blood viscosity. Viscosities for all groups (μ ) are measured by monitoring the hydrodynamic balanc-
ing state in the bridge channel (DBridge) of the microfluidic device (Fig. 5A). When a blood sample and 
PBS solution are delivered separately into the two inlets of the microfluidic device at the same flow rate 
of 1 mL/h, the pressure of blood sample (PBlood) at the left end of the bridge channel is larger than that of 
PBS solution at the right end on account of different fluidic resistance (Fig. 5B). Thus, the blood sample 
moves from the left-side to the right-side in the bridge channel, as depicted in Fig.  5B(a). As the PBS 
flow rate increases, the pressure of PBS solution is also increased and the blood flow passing through 
the bridge channel decreases. When the pressures of the blood sample and PBS solution at the both ends 
Figure 3. Velocity field measurement of a Newtonian fluid through SIV technique. (A) Microbubbles 
observed by an inverted fluorescence microscope with a 100× objective lens (NA of 1.3). (B) Size 
distribution of microbubbles measured by digital image processing techniques. (C) An instantaneous 
velocity field of PBS solution with microbubbles in the vascular phantom at a flow rate of 10 mL/h. The 
corresponding ultrasound image is superimposed on the velocity field data. (D) Normalized velocity profile 
(V/Vmax) along the normalized radial direction (r/R). The theoretical parabolic velocity profile is included for 
comparison. The flow rate of PBS solution is evaluated by Eq. (3).
www.nature.com/scientificreports/
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of the bridge channel reach to a hydrodynamic balancing state, the blood sample does not move to the 
bridge channel as depicted in Fig. 5B(d). When the pressure of PBS solution becomes higher than that of 
the balancing state, a reverse flow of PBS solution occurs in the bridge channel, as shown in Fig. 5B(e).
Viscosities of all groups are measured with varying flow rate. Given that blood viscosity is strongly 
dependent on shear rate, it is depicted with respect to the shear rate (Fig. 5C). The shear rate (γ ) of a 
blood flow in the microfluidic channel is approximately estimated using the following equation37,
Figure 4. Estimation of blood flow rate and dissociation of RBC aggregates using the SIV technique. (A) 
A typical velocity field and shear rate distribution of a blood flow in the vascular phantom at a flow rate of 
10 mL/h. (B) Variations of axial velocity profile (V) for RBCs in plasma along the normalized radial 
direction (r/R) at different flow rates. The magnified velocity profiles at very low flow rates are included. 
Error bars indicate standard deviation (n = 250). (C) Comparison of blood flow rates measured through SIV 
technique (QSIV) and the input flow rate of syringe pump (QPump) under various flow rate conditions (0.1-
300 mL/h). (a) The difference between the input flow rate and measured flow rate (QPump −  QSIV) is depicted 
in the Bland–Altman plot with respect to their average value (QMean). A bold line and dashed lines denote 
the mean value and 95% limits of agreement, respectively. (b) Variation of percentage error 
(Perror = (QPump −  QSIV)/QPump) (D) Variations of the decorrelation of speckles (DS) according to pseudo shear 
rate ( Pseudoγ ) for the four groups. Error bars indicate standard deviation (n = 2). (a) A schematic 
representation for the dissociation of RBC aggregates in a blood flow. RBC aggregates aligned with the flow 
direction at a specific time (t) are dissociated by shear force during the time interval (Δ t).
www.nature.com/scientificreports/
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
here, W and H denote the width and height of a rectangular channel, which are 3,000 and 80 μ m, respec-
tively, in this study.
As expected, the sample in the plasma behaves as a non-Newtonian fluid. The viscosities of sam-
ples treated with dextran have highest values compared with others over all shear rates because the 
dextran-treated plasma enhances RBC aggregation. The DIDS-treated plasma degrades the increase of 
blood viscosity according to the decrease of shear rate by inhibiting the formation of RBC aggregates. On 
the contrary, the viscosity of the RBCs suspended in PBS solution has a nearly constant value regardless 
of the shear rate because RBCs are completely dispersed in PBS solution.
Figure 5. Variations of blood viscosity and its relation to RBC aggregation. (A) A microfluidic device 
with two identical side channels and a connecting bridge channel. The width and height of the channels are 
3000 and 80 μ m, respectively. Blood sample and PBS solution are delivered into the left and right side 
channel, respectively. (B) Variation of pressure at the right side end of the bridge channel (PPBS) according to 
the flow rate of PBS solution (QPBS). Pressure at the left side end of the bridge channel (PBlood) is constant, 
because the blood flow rate is fixed at 1 mL/h. (a–e) Microscopic images showing flow conditions in the 
microfluidic device; the direction of blood flows passing through the bridge channel dependent on the flow 
rate of PBS solution. At the PBS flow rate of 4.95 mL/h, the pressures at the both ends of the bridge channel 
reach to the hydrodynamic balancing state. (C) Variations of blood viscosity (μ ) with respect to shear rate 
(γ

) for RBCs suspended in PBS solution, autologous plasma, dextran-treated and DIDS-treated plasmas with 
a hematocrit of 40%. (D) Relationship between the blood viscosity (μ ) and echogenicity (E). Solid line 
represents the linear-curve fitting. R value and the corresponding fitting equation are included. Dashed and 
dotted lines indicate 95% confidence and prediction intervals, respectively.
www.nature.com/scientificreports/
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Hemorheological properties under in vitro conditions. To investigate the relationship between 
the blood viscosity and RBC aggregation, viscosities of all samples are plotted against the echogenicity 
of the samples. Echogenicity averaged over the entire tube is linearly interpolated for matching the shear 
rates in the microchannel and vascular phantom. As depicted in Fig.  5D, the blood viscosity shows a 
linear relationship with the echogenicity of blood. A linear curve-fitting method is applied to all data 
and correlation coefficient value (R) of the fitting line is found to be approximately 0.93. This finding 
implies that the blood viscosity is highly correlated with RBC aggregation, regardless of blood treatments.
However, the hemorheological properties of blood samples are altered by in vitro exposure. To inves-
tigate these effects, blood viscosity, echogenicity, and decorrelation of speckles for the whole blood of a 
rat are measured after in vitro exposure of the collected blood samples. Similar to a previous study, the 
blood viscosity, and degree of RBC aggregation are considerably elevated with lapse of time (Table 1)22. 
This finding may be attributed to the change in the RBC shape from discocyte to echinocyte with the 
depletion of ATP. Therefore, hemorheological measurement should be carried out under ex vivo or in 
vivo conditions in order to more precise measure hemorheological properties.
Monitoring biophysical properties in the rat extracorporeal loop. Biophysical properties are 
repeatedly measured using hybrid technique at intervals of 20 min for a total of 100 min after establishing 
the extracorporeal rat bypass model (Fig.  6A). For varying hemorheological properties, dextran solu-
tion (6%) of 200 mg/kg is injected into the jugular vein of the rats at 50 min. For comparison between 
proposed technique and a previous method, a blood sample of 2 mL is collected at 40 min and 100 min.
Figure 6B shows temporal variation of flow rate of PBS solution (QPBS) at the hydrodynamic balancing 
state. By applying the SIV technique to ultrasound speckle images, the flow rate of the bypassing blood 
flow of the rat model is measured (QSIV). To determine the flow rate at the hydrodynamic balancing state 
using the previous method, additional measurement procedure is carried out using collected rat blood 
as introduced in the previous method (QPump)25. Although the flow rates measured by the SIV technique 
are slightly higher than those estimated by the previous method, the deviations are not so significant. 
The flow rates of PBS solution and blood samples at the hydrodynamic balancing states are gradually 
decreased during the experiment.
Figure 6C shows variations in the rectal temperature (T) and heart rate (HR). Although the heat pad 
is used to maintain the body temperature during the experiment, the body temperature of a rat is slightly 
decreased from 36 °C to 35 °C due to anesthesia and the extracorporeal circulation of blood. Heart rate 
is considerably varied from 100 to 180 bpm during the experiment. These values are smaller than that of 
a normal rat. This variation tendency is slightly correlated with the flow rate of blood (R = 0.56).
By substituting the flow rates of PBS solution and blood at hydrodynamic balancing state into Eq. 
(7), their blood viscosities (μ Blood) are measured at a specific measuring time. Although the injection 
of dextran and the decrease of flow rate have somewhat influence on the increment in blood viscosity, 
this variance is not noticeable (Fig. 6D). Pressure has a linear relation with the product of flow rate and 
viscosity as depicted in Eq. (1), while it is inversely correlated with blood viscosity (R = − 0.97). This 
discrepancy may be caused by large variance in the measured flow rate than blood viscosity. As shown in 
Fig. 6D, the mean pressure in the abdominal aorta is somewhat decreased at 60 min owing to collection 
of blood samples.
Hemorheological properties, such as echogenicity (E) and decorrelation of blood speckles (DS) can 
be continuously monitored using the proposed system. As shown in Fig.  6E, the injection of dextran 
solution at 50 min induces noticeable change in echogenicity, because the enhanced RBC aggregability 
augments ultrasound signals. However, the effect of dextran treatment on the decorrelation of speckles 
is not so significant. This results from very low degree of dissociation of RBC aggregates in blood flows 
at low shear conditions.
Discussion
RBC aggregation has been regarded as a crucial parameter in determining hemorheological conditions. 
An ultrasound examination has been widely used to characterize RBC aggregation in blood sample19,29,38. 
In the present study, RBC aggregations under various hemorheological conditions are estimated by ana-
lyzing ultrasound backscattered signals. Mean echogenicity and kurtosis in the center region are used in 
0 h 0. 5 h 1 h 2 h 3 h
μ (cP) 6.4 ±  0.2 7.4 ±  0.2 8.2 ±  0.1 11.0 ±  0.3 11.8 ±  0.1
E (dB) 20.09 ±  0.15 20.28 ±  0.13 20.42 ±  0.13 20.94 ±  0.23 21.14 ±  0.11
Ds 0.0644 ±  0.006 0.0551 ±  0.005 0.0503 ±  0.003 0.0481 ±  0.005 0.04423 ±  0.004
Table 1.  Variation of hemorheological properties in rat blood with the lapse of time after in vitro 
exposure. μ , E and Ds indicate the blood viscosity, the mean echogenicity and the deccorealtion of speckles. 
Each value represents mean ± standerd deviation.
www.nature.com/scientificreports/
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conducting quantitative analysis on RBC aggregation. The mean echogenicity exhibiting the degree of 
RBC aggregation is largely varied according to hemodynamic and hemorheological conditions (Fig. 2D). 
As shown in Fig.  2E, the kurtosis becomes zero when Rayleigh scattering is dominant in ultrasound 
signals. It is useful to figure out the concentration of RBC aggregates. However, the high degree of RBC 
aggregation under very low shear rate conditions also give rises to zero kurtosis. This implies that kur-
tosis is not a suitable parameter for monitoring the hemorheological variations in the rat extracorporeal 
model.
To measure the hemodynamic and hemorheological parameters of blood circulating in the rat extra-
corporeal loop without any collection of blood samples, the blood flow rate has to be accurately meas-
ured. The ultrasound system used for the flow measurement is validated using a Newtonian fluid and 
blood samples. Velocity profiles and flow rates of the PBS solution measured through the SIV technique 
show good consistency with the analytical solution and injection flow rate, respectively (Fig. 3). In addi-
tion, the blood flows measured by the SIV technique reasonably coincide with the flow rates supplied by 
the syringe pump (Fig. 4C). Since this ultrasound system can measures the hemodynamic and hemor-
heological information of blood flows simultaneously, an additional parameter of the decorrelation of 
Figure 6. Temporal variations of biophysical properties in the rat extracorporeal model. (A) A schematic 
of the microfluidic system used for monitoring the temporal variations of biophysical properties of blood 
circulating in the complex fluidic network. The fluidic network is established by connecting the abdominal 
aorta and jugular vein. (B) Temporal variations in flow rate of the PBS solution at the hydrodynamic 
balancing state (QPBS). The blood flow rates (QBlood) are measured by using the SIV technique (QSIV) and 
the previous method (QPump). Exactly blood samples of 2 mL are collected at 40 and 100 min to determine 
the blood flow rates by the previous method. Dextran solution (6%) is injected into the rat model at 50 min 
to enhance RBC aggregability. (C) Temporal variations of the rectal temperature (T) and heart rate (HR). 
(D) Temporal variations of the blood viscosity (μ Blood) and mean pressure at the abdominal aorta (PAorta). 
(E) Temporal variations of echogenicity (E) in the center of the tube (ranged from − 0.25 to 0.25 of the 
normalized radius) and the decorrelation of ultrasound speckles (DS).
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speckles can be obtained. Rouleaux are separated into either individual RBCs or small RBC aggregates 
when they are subjected to a shear force18,39. In the present study, the dissociation of RBC aggregates is 
estimated by analyzing the decorrelation of speckles. The low degree of decorrelation of speckles at a 
specific shear rate condition indicates a strong intercellular interaction of RBCs.
By monitoring the hydrodynamic balancing state in the microfluidic device, the temporal variations of 
blood viscosity are measured with high accuracy (Fig. 5). Since the blood viscosity and RBC aggregation 
of the same blood samples are measured by microfluidic device and ultrasound imaging system, their 
relation can be investigated directly (Fig. 5D). As a result, the blood viscosity is highly correlated with 
the mean echogenicity. This high correlation between blood viscosity and mean echogenicity supports 
that the increase of RBC aggregation augments blood viscosity, regardless of intercellular interaction of 
RBC and applied shear force.
After validating measurement accuracy of the combined techniques for RBC aggregation, blood flow 
rates, and blood viscosity under in vitro conditions, temporal variations of biophysical parameters are 
monitored under ex vivo condition (Fig. 6). To compare the measurement performance of the proposed 
method with that of previous method, blood sample is collected from the rat extracorporeal model 
during the experiment because the previous method found the flow rate of blood at the hydrodynamic 
balancing state using collected blood sample. In light of hemodynamic properties, the heart rate, blood 
flow rate and mean pressure at the abdominal aorta are considerably varied during the experiment. This 
kind of considerable variations may be attributed to the bleeding at coupling joints, anesthetization, 
environmental stress, and external collection of blood samples38.
Especially, the external collection of blood samples makes it difficult to accurately detect the temporal 
variations of hemorheological properties25. When hemorheological conditions are consistently varied in 
the rat extracorporeal model due to chemical treatments, previous methods should collect blood samples 
from the rat model at measurement instances. However, continuous collection of blood samples modifies 
the hemorheological properties of the circulating blood and ultimately induces biophysical damage to 
the rat model. In addition, the hemorheological properties are directly influenced by the in vitro expo-
sure of blood samples, as shown in Table 122. Considering that the method proposed in this study could 
consistently measure hemorheological properties without any blood collection, it might be useful to 
investigate the effects of chemical treatments on the hemodynamic and hemorheological characteristics 
in short-term.
In addition, the proposed system has a decisive advantage of providing information about the hemor-
heological properties of a rat model. Specifically, the information on blood viscosity at a high shear con-
dition can be obtained because blood flows are exposed to a noticeably high shear force that is caused 
by small channel size of the microfluidic device. In contrast, the shear rate induced in the vascular phan-
tom for ultrasound imaging is relatively small. This shear rate can be easily controlled by changing the 
region of interest for the analysis of RBC aggregation. Taking into account of high correlation between 
blood viscosity and RBC aggregation (Fig.  5D), the hemorheological properties of blood flows can be 
simultaneously measured at different shear conditions. This measurement under various shear rate con-
ditions can easily and accurately distinguish the variations of hemorheological properties. For example, 
the injection of dextran solution does not induce a noticeable change in blood viscosity. However, mean 
echogenicity is considerably increased by dextran treatment. Thus, the elevated RBC aggregation can be 
easily detected by monitoring ultrasound signals.
The feasibility and measurement accuracy of the proposed system for monitoring temporal variations 
of the various biophysical properties under ex vivo condition are demonstrated. However, the cannula-
tion of large-size abdominal aorta in a rat model to supply blood to the extracorporeal loop gives rise 
to physiological limitation in long-term monitoring of various biophysical properties. To investigate the 
effects of drugs or chemicals for long-term treatment on hemorheological properties using present exper-
imental system, a series of the same experiment using rat samples having different drug administration 
times should be carried out or this system has to be improved to apply to large-size animal models such 
as fig or dog. Because large-size animals circulate a large amount of blood with high blood pressure, it 
is possible to supply test blood to the extracorporeal loop by cannulation between the small vein and 
artery. The carefully handling large animals helps to monitor the temporal variations of hemodynamic 
and hemorheological properties for relatively long period of time. Besides a cannulation, measurement 
modalities of this hybrid system should be integrated into one device for clinical applications. From these 
improvements, this system would be useful for better understanding of the relationship between CVDs 
and biophysical parameters, and it can be utilized as a complementary diagnostic modality to monitor 
the variations in hemorheological and hemodynamic parameters under ex vivo conditions such as blood 
dialysis.
Methods
Blood sample preparation. In this study, male Sprague-Dawley (SD) rats with body weight in the 
range of 398–416 g are tested. All blood samples, collected through an abdominal aortic puncture under 
intramuscular ketamine (100 mg/kg) and xylazine (10 mg/kg) anesthesia, are anticoagulated with eth-
ylenediaminetetraacetic acid (EDTA) dipotassium salt (1.5 mg of EDTA per 1 mL of blood). The blood 
samples are divided into four groups: RBCs suspended in PBS (pH 7.4, Bio Solution, Korea), autolo-
gous plasma, dextran-treated plasma and DIDS-treated plasma. Each group has two samples. For the 
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DIDS-treated sample, blood is taken at 30 min after injecting 50 mg/kg of DIDS to jugular vein19. The col-
lected blood samples are separated into RBCs and plasma through centrifugation. Subsequently, the buffy 
layer is removed. Dextran 500 (molecular mass 450–550 kDa; Sigma) in PBS (6%) is mixed with plasma 
to archive a plasma-dextran concentration of 0.6% in the dextran-treated blood sample. The hematocrit 
of all blood samples is precisely adjusted to be 40% by carefully mixing RBCs with four different solu-
tions (PBS solution, autologous plasma, plasma-dextran and plasma-DIDS mixtures). All procedures 
performed on the animals are approved by the Animal Care and Ethics Committee of POSTECH and 
the methods are carried out in accordance with the approved guidelines.
Fabrication of the microfluidic device. A rectangular master replica molder (height = 80 μ m) is 
fabricated using MEMS technologies based on soft lithography process and deep reactive-ion etching. 
The microfluidic device has two identical side channels (width = 3000 μ m, length = 14.4 mm) connected 
by a bridge channel (width = 100 μ m, length = 2.4 mm) as shown in Fig. 5A. After pouring polydimethyl-
siloxane (PDMS) (Sylgard 184, Dow Corning, USA) is poured on the silicon molder, it is cured at 80 °C 
for 3 h. Thereafter, a PDMS block is peeled off from the silicon molder. Two side channels have their 
respective inlet and outlet made of a 1 mm diameter puncher. After oxygen-plasma treatment (CUTE, 
Femto Science, Korea), the microfluidic device is finally prepared by bonding the PDMS block with a 
glass substrate. Prior to the experiments, channels of the microfluidic device are incubated with 2% 
bovine serum albumin (Sigma, MO) for 10 min at room temperature to prevent adhesion of cells.
Experimental setup. Figure 2A shows the experimental setup for ultrasound imaging. A total 255 of 
ultrasound speckle images are obtained with a 35-MHz mechanical sector-scan probe (Capistrano Labs., 
San Clemente, CA, USA) at a frame rate of 50 fps with a sector angle of 20°. To minimize the acoustic 
discrepancy caused by the tube wall, a vascular phantom with an inner diameter of 1000 μ m is adopted 
to acquire ultrasound images. The details of the vascular phantom are described in our previous study28. 
The measurement section over the agarose vascular phantom is covered with water to facilitate acoustic 
transmission. The center of the lumen is positioned at the focal length of the transducer (11.8 mm). The 
transducer chamber, filled with degassed water, is covered with a thin membrane.
Blood sample is supplied into the vascular phantom and the left-side channel of the microfluidic device 
through syringe pump (neMESYS, Centoni Gmbh, Germany) with a 5 mL plastic syringe (BD). PBS solu-
tion is delivered into the right-side channel of the microfluidic device as a reference fluid through the 
syringe pump. The flow rates of PBS solution are adjusted according to the designed flow conditions for 
each blood sample. To monitor the flow conditions in the microfluidic device, the microfluidic device is 
mounted on a stereo microscope (Stemi 2000-C, Zeiss, Germany) equipped with a digital camera (D700, 
Nikon, Japan). Optical images of the microfluidic device are captured with a magnification of 0.8× . All 
experiments are conducted at room temperature (25 °C).
Speckle image velocimetry (SIV). Velocity fields of the PBS and blood flows are measured using 
a SIV technique based on a cross-correlation algorithm. Before applying the SIV technique to speckle 
images, the ultrasound images captured around the blood vessel are cropped into the images of 320 × 84 
pixels in size. To enhance the measurement performance of the SIV technique, the captured images are 
processed by applying digital image-processing techniques and a binary mask is applied to the near-wall 
region. The detailed procedure and the image-processing techniques used in the present study are well 
described in our previous studies26,28,35. The size of the interrogation window along the radial direction is 
fixed to six pixels (0.11 mm in physical dimension) with 50% overlapping. Since the stream wise velocity 
is largely varied according flow rates, interrogation windows of various sizes are adopted along the flow 
direction. The obtained velocity vectors are filtered using a 3 × 3 Median kernel to minimize errors.
Ultrasound agent. To demonstrate the measurement accuracy of the ultrasound system, a flow of 
PBS solution seeded with ultrasound agent of Sonazoid (GE Healthcare, Oslo, Norway) is measured 
through SIV technique. A Sonazoid of 0.5% concentration is circulated using a syringe pump. For size 
measurement of microbubbles, optical images of microbubbles observed by an inverted optical micro-
scope (Zeiss, Germany) with 100× objective lens are converted into binary images with an optimal 
thresholding value determined through Otsu’s algorithm40. A relative diameter is evaluated using the 
area of microbubbles in binary images. Figure 3B shows the size distribution of microbubbles with mean 
and standard deviations of 2.13 and 0.55 mm, respectively.
Data analysis for ultrasound blood speckles. Statistical analysis of ultrasound signals has been 
used to investigate RBC aggregation19,29. The coefficient of Kurtosis (K) which represents the peakedness 
of the probability distribution of speckle image, is calculated using the following equation:
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where E is the expectation operator, X is the uncompressed envelop amplitude, and m denotes the mean 
value. A leptokurtic distribution which has an acute peak around the mean value provides a positive 
Kurtosis. In contrast, a platykurtic distribution induces a negative Kurtosis.
A decorrelation of blood speckles (DS) based on the speckle similarity can be used to estimate the 
dissociation of RBC aggregates during a given time interval (Δ t)35. At first, tile 1 is selected at the center 
of a speckle image. To compensate the decorrelation caused by the movement of speckle patterns, the tile 
2 in the subsequent image is shifted as much as the displacement of speckles estimated through the SIV 
technique. The decorrelation of blood speckles is calculated by subtracting structural similarity index41 
between the two tiles from 1 as follows;
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where mt1, mt2 and σ t1, σ t2 denote the mean intensity and standard deviation of tiles 1 and 2, respectively. 
σ t1t2 denotes the covariance of tiles 1 and 2. C1 and C2 are two small positive constants and they are 
normally set to be 0.01 and 0.03, respectively. The size of the two tiles used in this analysis is 32 × 32 
pixels (0.6 × 0.6 mm).
Viscosity estimation. Given that the pressures at two identical side channels are identical at hydro-









Here, QBlood, QPBSB denote the flow rate of blood sample and PBS solution at the hydrodynamic balancing 
condition, respectively. Viscosity of the PBS solution (μPBS) is approximately 1.00 ± 0.05 cP24.
Variation of hemorheological properties after in vitro exposure. Whole blood samples of two 
rats are extracted through abdominal aortic puncture. Blood viscosity and RBC aggregation are meas-
ured at a shear rate of 86.8 and 1.8 s−1, respectively. Mean value of hematocrit for the blood samples is 
48.0 ± 1.5.
Preparation of a rat extracorporeal loop model. A male SD rat (16 weeks old, body weight of 
427.8 g) is anesthetized with intramuscular injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). A 
PE-50 (ID = 0.58 mm, polyethylene tube) tube at one end of the bypass loop is cannulated into the 
right jugular vein. Although there are lots of academic controversies over the use of heparin as an 
anti-coagulant in the measurement of hemorheological properties, heparin has been commonly and 
essentially injected into ex vivo animal models to prevent blood coagulation inside vascular conduits. 
The exact amount of heparin (1500 IU/mL/kg) is precisely injected into the right jugular vein. After 
10 min of heparin injection, a 22G catheter is inserted into the abdominal aorta. Prior to the connection 
of extracorporeal conduits to the rat model, the conduits are incubated with 2% bovine serum albumin 
(BSA, Sigma, MO) for 1 h at room temperature to block platelet deposition and fibrin adhesion. A silicon 
tube (ID = 0.8 mm) at the other end of the loop is connected with the catheter. As shown in Fig.  6A, 
pulsed-free microfluidic device with an air cavity of 0.5 mL is connected between the aorta and the inlet 
of the microfluidic device to supply stabilized blood sample. A vascular phantom is connected with the 
outlet of the microfluidic device to estimate the hemodynamic characteristics of blood flow and RBC 
aggregation through the ultrasound system. The blood passing through the extracorporeal conduits is 
returned to the jugular vein of the rat model. For this, the outlet of the vascular phantom is connected 
with another PE-50 tube. Since blood cooled by extracorporeal circulation can cause hypothermia, bio-
physical properties including rectal temperature, heart rate, and electrocardiogram are monitored using 
a physiological monitoring unit (MouseMonitor, Indus Instruments, USA). Based on these information, 
the temperature of animal model is maintained by using a heat pad to inhibit hypothermia that can 
be possibly caused during ex vivo measurement. However, the environmental room temperature which 
is different from body temperature can induce overestimation of blood viscosity and underestimation 
of RBC aggregation, compared to the hemorheological properties measured under in vivo conditions. 
Preliminary experimental results show that blood viscosity at a shear rate of 8.68 s−1 is reduced approx-
imately 10.4%, while echogenicity at a shear rate of 0.28 s−1 is increased approximately 1.6%, as the 
environmental temperature is increased from 25 °C to 37 °C. All experimental procedures are approved 
by the Animal Care and Ethics Committee of POSTECH and the methods are carried out in accordance 
with the approved guidelines.
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